Why Merck Stock Is Heating Up Today
What happened Pharma giant Merck (NYSE:MRK) saw its shares rise by a healthy 9% in premarket
Merck
Merck (MRK) Announces Positive Topline Results from PNEU-DIRECTION (V114-027) and PNEU-PLAN (V114-024) Phase 3 Pediatric Studies for V114, Merck’s Investigational 15-valent Pneumococcal Conjugate Va
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here. Merck (NYSE:
Merck, Novocure Team Up On Lung Cancer Treatment; Trial Set For 2H20
Merck (MRK) and Novocure (NVCR) have entered into a clinical trial collaboration agreement to develop